학술논문

Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer
Document Type
article
Source
Gastroenterology. 152(5)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Genetic Testing
Clinical Research
Orphan Drug
Genetics
Cancer
Digestive Diseases
Rare Diseases
2.1 Biological and endogenous factors
Aetiology
Aged
Aged
80 and over
BRCA1 Protein
DNA-Binding Proteins
Fanconi Anemia Complementation Group N Protein
Female
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Male
Middle Aged
Mutation
Nuclear Proteins
Recombinational DNA Repair
Stomach Neoplasms
Tumor Suppressor Proteins
Stomach
Tumor
WES
Interaction
Latin American Gastric Cancer Genetics Collaborative Group
Clinical Sciences
Neurosciences
Paediatrics and Reproductive Medicine
Gastroenterology & Hepatology
Clinical sciences
Nutrition and dietetics
Language
Abstract
Up to 10% of cases of gastric cancer are familial, but so far, only mutations in CDH1 have been associated with gastric cancer risk. To identify genetic variants that affect risk for gastric cancer, we collected blood samples from 28 patients with hereditary diffuse gastric cancer (HDGC) not associated with mutations in CDH1 and performed whole-exome sequence analysis. We then analyzed sequences of candidate genes in 333 independent HDGC and non-HDGC cases. We identified 11 cases with mutations in PALB2, BRCA1, or RAD51C genes, which regulate homologous DNA recombination. We found these mutations in 2 of 31 patients with HDGC (6.5%) and 9 of 331 patients with sporadic gastric cancer (2.8%). Most of these mutations had been previously associated with other types of tumors and partially co-segregated with gastric cancer in our study. Tumors that developed in patients with these mutations had a mutation signature associated with somatic homologous recombination deficiency. Our findings indicate that defects in homologous recombination increase risk for gastric cancer.